Clinical Trial Update: Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 trial compares the safety and efficacy of acarbose plus saxagliptin versus metformin plus saxagliptin in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Saxagliptin (saxagliptin)
• metformin (metformin)

Snippet

Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN